Surgical Science Sweden AB (publ)
- Jurisdiction
Sweden - LEI
549300YROAI18G6JL885 - ISIN
SE0014428512 (SUS.ST )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. Read full profile
Stock price
Fundamentals
- Net revenue
€86.26M - Gross margin
67.9% - EBIT
€7.91M - EBIT margin
9.2% - Net income
€8.45M - Net margin
9.8%
Statement period: - (published )
Dividends
No dividend payouts